Global Non-Specific Endonuclease Market to Reach USD 183 Billion by 2032 | CAGR 13.9% According to a newly published market research report by 24LifeSciences, global Non-Specific Endonuclease market was valued at USD 78.5 million in 2024 and is projected to reach USD 183 million by 2031, growing at a compound annual growth rate (CAGR) of 13.9% during the forecast period 2025–2031. Non-Specific Endonucleases represent a crucial class of enzymes capable of cleaving phosphodiester bonds within DNA or RNA molecules without sequence specificity. Unlike their restriction enzyme counterparts that target specific nucleotide sequences, these enzymes perform random cuts across molecular chains, making them indispensable tools for the complete degradation of nucleic acids. Their ability to process all nucleic acid forms—including single-stranded, double-stranded, linear, circular, and both natural and denatured variants—underpins their importance across numerous applications. These include vital processes in genomics research, RNA degradation protocols, sample preparation workflows, and specialized nucleic acid modification experiments where broad-spectrum cleavage is required. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4991/non-specific-endonuclease-market

Top 10 Companies Leading the Grating-Coupled Interferometry Market According to a newly published market research report by 24LifeSciences, global Grating-Coupled Interferometry (GCI) market was valued at USD 57.7 million in 2023 and is projected to reach USD 132 million by 2030, growing at a compound annual growth rate (CAGR) of 8.9% during the forecast period 2025–2030. Grating-Coupled Interferometry (GCI) is a sophisticated chip-based label-free biosensor technology renowned for its exceptional sensitivity and high signal-to-noise ratio, which is revolutionizing how researchers study molecular interactions. This breakthrough technology stands apart from traditional fluorescence and immunological label-dependent techniques by delivering comprehensive data on binding presence, specificity, affinity, and kinetic constantsall without requiring complex sample preparation. Its ability to work with crude biological samples makes it particularly valuable for accelerating drug discovery pipelines and providing more physiologically relevant data in near-native conditions. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3783/grating-coupled-interferometry-gci--global-outlook-and-market

Global RSV Diagnostics Market Projected to Grow at a CAGR of 9.4% According to a newly published market research report by 24LifeSciences, global RSV diagnostics market was valued at USD 795 million in 2025 and is projected to grow from USD 870 million in 2026 to reach USD 1,470 million by 2034, growing at a compound annual growth rate (CAGR) of 9.4% during the forecast period. Respiratory Syncytial Virus (RSV) diagnostics encompass the critical tests and methods used to detect the presence of the virus, a leading cause of severe lower respiratory tract infections worldwide. Primarily affecting vulnerable populations such as infants, young children, and older adults, these diagnostics include rapid antigen detection tests (RADTs), molecular assays like PCR, and viral culture techniques, each offering different levels of speed and specificity for clinical decision-making in both hospital and outpatient settings. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9340/rsv-diagnostics-market

Top 10 Players Shaping the Global Hepatitis E Diagnostic Tests Market (2026–2034) According to a newly published market research report by 24LifeSciences, global Hepatitis E Diagnostic Tests market is valued at USD 40.1 million in 2026 and is projected to reach USD 47.1 million by 2034, growing at a compound annual growth rate (CAGR) of 2.4% during the forecast period. Hepatitis E diagnostic tests are critical medical tools designed to detect the presence of the Hepatitis E Virus (HEV), an RNA virus responsible for acute liver inflammation. These tests are indispensable for confirming infection, particularly during outbreaks and for high-risk populations such as pregnant women, immunocompromised individuals, and patients with pre-existing liver conditions. The primary diagnostic methodologies include Enzyme-Linked Immunosorbent Assay (ELISA) kits, which identify IgM and IgG antibodies, and advanced molecular techniques like Reverse Transcription-Polymerase Chain Reaction (RT-PCR) tests that detect viral RNA directly, offering high specificity and sensitivity. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9474/hepatitis-e-diagnostic-tests-market